Recent personnel actions at the HHS and DEA may be boding well … or not … for the re-uptake of the proposed marijuana rescheduling from Schedule I of the Controlled Substances Act to Schedule III. The first is the naming...

With cannabis being regulated at the state level of the 39 states that have legalized at least medical marijuana, there are dozens of variations on the requirements for pesticide and other chemical contamination testing, inspection, and enforcement. That variation has...

It’s been a long time coming, but the hearing for the proposed rescheduling of marijuana has finally been set. On January 21, 2025, the government will present its case, followed by 17 days of testimony from various state and organization...

While the proposed rescheduling of marijuana to a Schedule III drug remains up in the air, a number of other events are taking place that will likely bring down some of the recent highs of the CBD and THC industry....

On May 16, 2024, The Drug Enforcement Administration, Department of Justice published a proposal to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act. The proposal is based on the views of the Department of Health...

Despite the six months that have passed since the Department of Health and Human Services (HHS) recommendation to the Drug Enforcement Agency (DEA) to reclassify marijuana as a Schedule III drug from its current status as Schedule I, there has...

With four states adding or updating marijuana legislation in 2023, only 10 states remain as outliers, allowing no legal medical or adult-use marijuana. Coming on board the adult-use train this year were Delaware, Minnesota and Ohio, with Kentucky passing its...

What cannabis policies are U.S. federal agencies prioritizing? What do they see as the potential impacts of its legalization and use? Although many states have legalized cannabis, many public health implications have not been fully evaluated, and a group of...

The disconnect between the state and federal governments on cannabis legislation is showing itself in the medical community as well. In late September, the American Nurses Association (ANA) announced its formal recognition of cannabis nursing as a nursing specialty, along with...

As you likely have seen by now, a federal recommendation has been made to reclassify marijuana as a Schedule III drug from its current status as Schedule I. What instigated the recommendation, what does it mean to the industry, and...